Monogenic diabetes: Old and new approaches to diagnosis

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 13, Issue 3, 2013, Pages 278-281

  Owen, Katharine R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Aetiology of diabetes; Glycolytic enzyme glucokinase (gck); Hnf1a; Maturity onset diabetes of the young (mody); Monogenic diabetes

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLICLAZIDE; GLYCAN; INSULIN; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HNF1A PROTEIN, HUMAN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; GENETIC ASSOCIATION; GENETIC SCREENING; GENOME; HUMAN; MALE; MOLECULAR DIAGNOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; AETIOLOGY OF DIABETES; ALGORITHM; BLOOD; DIFFERENTIAL DIAGNOSIS; GENETICS; GLYCOLYTIC ENZYME GLUCOKINASE (GCK); HNF1A; INSULIN DEPENDENT DIABETES MELLITUS; MATURITY-ONSET DIABETES OF THE YOUNG (MODY); METABOLISM; MONOGENIC DIABETES; MUTATION; PROGNOSIS;

AETIOLOGY OF DIABETES; GLYCOLYTIC ENZYME GLUCOKINASE (GCK); HNF1A; MATURITY-ONSET DIABETES OF THE YOUNG (MODY); MONOGENIC DIABETES;

ADULT; ALGORITHMS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 1; DIAGNOSIS, DIFFERENTIAL; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; MUTATION; PROGNOSIS;

EID: 84884527899     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.13-3-278     Document Type: Article

References (17)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35:S64-71.
2. Molven A, Njolstad PR. Role of molecular genetics in transforming diagnosis of diabetes mellitus. Expert Rev Mol Diagn 2011;11:313-20.
3. Pearson ER, Starkey BJ, Powell RJ et al. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003;362:1275-81.
4. Stride A, Vaxillaire M, Tuomi T et al. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 2002;45:427-35.
5. Thanabalasingham G, Pal A, Selwood MP et al. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young. Diabetes Care 2012;35:1206-12.
6. Diabetes Genes. Genetic diabetes nurses locations map. www.diabetesgenes.org/content/genetic-diabetes-nurses-locations-map [Accessed 7 April 2013].
7. Shields BM, Hicks S, Shepherd MH et al. Maturityonset diabetes of the young (MODY): how many cases are we missing? Diabetologia 2010;53:2504-8.
8. Tattersall R. Maturity-onset diabetes of the young: A clinical history. Diabetic Med 1998;15:11-4.
9. Bellanne-Chantelot C, Levy DJ, Carette C et al. Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene. J Clin Endocrinol Metab 2011;96:E1346-51.
10. Owen KR, Skupien J, Malecki MT. The clinical application of nongenetic biomarkers for differential diagnosis of monogenic diabetes. Diabetes Res Clin Pract 2009;86:S15-21.
11. Owen KR, Thanabalasingham G, James TJ et al. Assessment of highsensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations. Diabetes Care 2010;33:1919-24.
12. Thanabalasingham G, Shah N, Vaxillaire M et al. A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia 2011;54:2801-10.
13. McDonald TJ, Shields BM, Lawry J et al. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care 2011;34:1860-2.
14. Lauc G, Essafi A, Huffman JE et al. Genomics meets glycomics - the first GWAS study of human N-glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation. PLoS Genet 2010;6:e1001256.
15. Thanabalasingham G, Huffman J, Kattla J et al. Mutations in HNF1A result in marked alterations of plasma glycan profile. Diabetes 2013;62:1329-37.
16. Armendariz AD, Krauss RM. Hepatic nuclear factor 1-alpha: inflammation, genetics, and atherosclerosis. Curr Opin Lipidol 2009;20:106-11.
17. Diabetes Genes. MODY probability calculator. www.diabetesgenes.org/ content/mody-probability-calculator [Accessed 7 April 2013].